AI-generated summary
The authors reviewed nine animal studies, all in canine models, assessing photobiomodulation for experimentally induced peri-implant bone defects. They report that about 89% of the studies showed more new bone formation in treated defects than in controls. The authors state that the clinical efficacy remains unclear because of high heterogeneity and high risk of bias across studies.
- Studies included
- 9
- Who or what was studied
- Canine models with experimentally induced peri-implant osseous defects, using split-mouth design
- Limits stated in the abstract
- The authors note high heterogeneity and high risk of bias among the included preclinical studies, and that clinical significance remains unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photodynamic therapy, Heterogeneity. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.